2 unknown. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Unknown 2 |
Follow Long Covid19: new trials by email Literature Review of Long Covid19 trials Research Report on Long Covid19
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Treatment of Post-COVID-19 With Hyperbaric Oxygen Therapy: a Randomized, Controlled Trial Hyperbaric oxygen - Post-COVID-19 Syndrome, Post-COVID Syndrome | Phase 3 | Unknown | Erasmus Medical Center | 120 | 2024-10-01 | 2024-02-28 |
| IMMUNERECOV CONTRIBUTES TO IMPROVEMENT OF RESPIRATORY AND IMMUNOLOGICAL RESPONSE IN POST-COVID-19 PATIENTS. Nutritional blend (ImmuneRecov). - Long Covid19, Dietary Supplements | Phase 3 | Unknown | Federal University of São Paulo | 58 | 2023-12-10 | 2023-12-12 |
Post-Acute COVID-19 Syndrome (2) · COVID-19 (1) · Inflammation (1) · Respiratory Tract Infections (1)
Chronic Disease (2) · Coronaviridae Infections (2) · Coronavirus Infections (2) · Disease Attributes (2) · Infections (2) · Lung Diseases (2) · Nidovirales Infections (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Pneumonia (2) · Pneumonia, Viral (2) · Post-Infectious Disorders (2) · RNA Virus Infections (2) · Respiratory Tract Diseases (2) · Virus Diseases (2)
Erasmus Medical Center (1) · Federal University of São Paulo (1)
Brazil (1) · Netherlands (1)